SCHEMBL747448

SCHEMBL747448

CN1CC(=O)N2[C@@H](Cc3ccc(O)cc3)C(=O)N(CC(c3ccccc3)c3ccccc3)C[C@@H]2N1C(=O)NCc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 18/20 0.52
CTNNB1 P35222 2/20 0.52
TCF7 P36402 2/20 0.52
BCL9 O00512 1/20 0.52
TCF4 P15884 1/20 0.52
CLPP Q16740 1/20 0.52
CREBBP Q92793 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL745558 0.96 CLPP (0.49) CYP3A4CTNNB1TCF7BCL9TCF4
SCHEMBL747121 0.95 CYP3A4 (0.48) CYP3A4CTNNB1TCF7BCL9TCF4
SCHEMBL10226398 0.94 CYP3A4 (0.54) CYP3A4CTNNB1TCF7BCL9TCF4
SCHEMBL13757616 0.94 CYP3A4 (0.52) CYP3A4CTNNB1TCF7BCL9TCF4
SCHEMBL744801 0.94 CYP3A4 (0.52) CYP3A4CTNNB1TCF7BCL9TCF4
SCHEMBL764059 0.93 CYP3A4 (0.52) CYP3A4CTNNB1TCF7BCL9TCF4
SCHEMBL12152953 0.93 CYP3A4 (0.52) CYP3A4CTNNB1TCF7BCL9TCF4
SCHEMBL745999 0.93 CYP3A4 (0.46) CYP3A4CTNNB1TCF7BCL9TCF4
SCHEMBL744497 0.93 CYP3A4 (0.54) CYP3A4CTNNB1TCF7BCL9TCF4
SCHEMBL10267288 0.91 CYP3A4 (0.51) CYP3A4CTNNB1TCF4CLPPCREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8729262-B2 Reverse-turn mimetics and method relating thereto CHOONGWAE PHARMA CORPORATION (KR) 2014-05-20 US disclosed
US-8318738-B2 Reverse-turn mimetics and method relating thereto CHOONGWAE PHARMA CORPORATION (KR) 2012-11-27 US disclosed
US-8138337-B2 Reverse-turn mimetics and method relating thereto CHOONGWAE PHARMA CORPORATION (KR) 2012-03-20 US disclosed
US-8106049-B2 Reverse-turn mimetics and method relating thereto CHOONGWAE PHARMA CORPORATION (KR) 2012-01-31 US disclosed
US-8101751-B2 Reverse-turn mimetics and method relating thereto CHOONGWAE PHARMA CORPORATION (KR) 2012-01-24 US disclosed
US-8101751-B2 Reverse-turn mimetics and method relating thereto CHOONGWAE PHARMA CORPORATION (KR) 2012-01-24 US disclosed
US-8049008-B2 Reverse-turn mimetics and method relating thereto CHOONGWAE PHARMA CORPORATION (KR) 2011-11-01 US disclosed
US-7932384-B2 Reverse-turn mimetics and method relating thereto CHOONGWAE PHARMA CORPORATION (KR) 2011-04-26 US disclosed
US-7671054-B1 Reverse-turn mimetics and method relating thereto CHOONGWAE PHARMA CORPORATION (KR) 2010-03-02 US disclosed
US-7585862-B2 Colorectal cancer, restenosis associated with angioplasty, polycystic kidney disease, aberrant angiogenesis disease, rheumatoid arthritis disease, tuberous sclerosis complex, Alzheimer's disease, excess hair growth or loss CHOONGWAE PHARMA CORPORATION (KR) 2009-09-08 US disclosed
US-7576084-B2 Reverse-turn mimetics and method relating thereto CHOONGWAE PHARMA CORPORATION (KR) 2009-08-18 US disclosed
US-7576084-B2 Reverse-turn mimetics and method relating thereto CHOONGWAE PHARMA CORPORATION (KR) 2009-08-18 US disclosed
US-7566711-B2 Reverse-turn mimetics and method relating thereto CHOONGWAE PHARMA CORPORATION (KR) 2009-07-28 US disclosed
US-7566711-B2 Reverse-turn mimetics and method relating thereto CHOONGWAE PHARMA CORPORATION (KR) 2009-07-28 US disclosed
US-7232822-B2 Reverse-turn mimetics and method relating thereto CHOONGWAE PHARMA CORPORATION (KR) 2007-06-19 US disclosed